Drug ID:Drug149
Drug Name:GED-0507-34-Levo
CID:67008033
DrugBank ID:DB16109
Modality:Small Molecule
Groups:NULL
US Approved:NULL
Other Approved:NULL
Identifier: NCT02808390
Molecular Formula:C10H13NO3
Molecular Weight:195.21 g/mol
Isomeric SMILES:CO[C@@H](CC1=CC=C(C=C1)N)C(=O)O
Synonyms:921195-93-9; GED-0507-34-levo; Y4H78S56YZ; GED-0507-34L; UNII-Y4H78S56YZ; (S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic acid; Benzenepropanoic acid, 4-amino-alpha-methoxy-, (alphaS)-; BENZENEPROPANOIC ACID, 4-AMINO-.ALPHA.-METHOXY-, (.ALPHA.S)-; (S)-3-(4-Aminophenyl)-2-methoxypropanoic acid; (S)-3-(4-Aminophenyl)-2-methoxypropanoicacid
Phase 0: 0
Phase 1: 0
Phase 2: 0
Phase 3: 0
Phase 4: 0
Description:NULL

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
dt1180 67008033 GED-0507-34-Levo 5468 PPARG Homo sapiens (human) Agonist

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT02808390 Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC PHASE2 TERMINATED PPM Services S.A. Ulcerative Colitis DRUG: GED-0507-34-Levo 80 mg|DRUG: GED-0507-34-Le… Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
No data available

No related literature

You can run management commands to establish drug-literature associations